Triple CFTR modulator therapy is associated with improved endocrine pancreatic function in patients with cystic fibrosis
C. Steinack (Zurich , Switzerland), T. Gaisl (Zurich, Switzerland), F. Beuschlein (Zurich, Switzerland), S. Macé Matthew (Zurich , Switzerland), M. Ernst (Zurich , Switzerland)
Source: International Congress 2022 – Advances in cystic fibrosis research
Session: Advances in cystic fibrosis research
Session type: Oral Presentation
Number: 2918
   
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Steinack (Zurich , Switzerland), T. Gaisl (Zurich, Switzerland), F. Beuschlein (Zurich, Switzerland), S. Macé Matthew (Zurich , Switzerland), M. Ernst (Zurich , Switzerland). Triple CFTR modulator therapy is associated with improved endocrine pancreatic function in patients with cystic fibrosis. 2918
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|